We have located links that may give you full text access.
Plombage Thoracoplasty in the Current Medical Practice.
Chest 2012 October 2
SESSION TYPE: Thoracic Surgery Posters IPRESENTED ON: Wednesday, October 24, 2012 at 01:30 PM - 02:30 PMPURPOSE: The purpose of this study is to evaluate the late imagistic and clinical features of the patients with a history of plombage thoracoplasty for tuberculosis (TB) admitted to our unit.METHODS: Between 01.01.1990-01.01.2012 we admitted in our clinic a total number of 5 patients with a history of plombage thoracoplasty. The plombage was performed with: balls (2 cases), autologous rib (2 cases) and oil-filled bag (1case). All the innitial procedures were performed on other units or by other surgeons, plombage thoracoplasty being abandoned by our team. The interval between the plombage thoracoplasty and admittance to our unit ranged between 7 and 46 years (average 29).RESULTS: 2 patients were admitted for complications related to the plombage thoracoplasty - recurrence and overinfection requiring reoperation (removal of the plombage material and thoracomyoplasty). One patient presented a contralateral empyema and two patients presented no thoracic complaints. The plombage material was obvious on both CXR and CT scans in all cases. At one year follow-up, the operated patients presented no recurrence and no significant thoracic complaints. One patient died of causes unrelated to the plombage thoracoplasty (myocardial infarction).CONCLUSIONS: Late survivors of plombage thoracoplasty may be encountered in the current medical practice. They may present with complications related to plombage thoracoplasty or for other health problems.CLINICAL IMPLICATIONS: Although plombage thoracoplasty is a hystorical procedure, doctors involved with the treatment of chest diseases should be familiar with the imagistic and clinical features of these procedures since they may meet late survivors with or without complications related to the plombage material.DISCLOSURE: The following authors have nothing to disclose: Petre Vlah-Horea Botianu, Alexandru-Mihail BotianuNo Product/Research Disclosure InformationUniversity of Medicine and Pharmacy, Tirgu-Mures, Romania.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app